Skip to main content
. 2022 Apr 29;13:860487. doi: 10.3389/fpsyt.2022.860487

TABLE 5.

Confidence in symptom-based diagnoses and the willingness to take medications for symptom control.

Confidence on the diagnosis (0–10, from not confidence at all to very confident) Statistics
(Q3) Confidence on the diagnosis of major depressive disorder based on symptoms# N Mean SD Median Min Max
14 5.50 2.31 5.5 1 9
(Q4) Willingness to take medication for symptoms* N Mean SD Median Min Max
14 5.50 2.31 5.5 1 9
(Q28) Confidence on the diagnosis of non-solid brain tumor based on symptoms# N Mean SD Median Min Max
13 1.62 2.33 1 0 7
(Q29) Willingness to take medication for symptoms* N Mean SD Median Min Max
13 3.38 3.52 2 0 9
(Q30) Confidence on the diagnosis of mental illnesses in the end of the survey N Mean SD Median Min Max
13 3.92 2.72 5 0 8

#p < 0.001, based on the Wilcoxon rank sum test.

*p = 0.1, based on the Wilcoxon rank sum test. The medications were assumed to have the same efficacy to treat symptoms of the diagnoses: 40–60% effectiveness for patients, while placebo worked for 20% to 40% of the patients (17).

p = 0.16, compared with the confidence in the diagnosis of major depressive disorder based on symptoms (Q3) using the Wilcoxon rank sum test. SD, standard deviation.